Skip to main content
TARS logo

TARS · Tarsus Pharmaceuticals, Inc.

$57.93 -1.01 (-1.71%)
Market Cap
$2.52B
Shares
43.02M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 253
Total Value: $3,171,322,449
Total Shares: 45,366,804
Showing 1–100 of 259 holdings by value · page 1 of 3

Institutional Ownership Trend

23 quarters

Holder Concentration

Across 253 13F filers
Top Holder
7.9%
Jun 2023 → Mar 2026 · range 7.5% – 11.9%
of institutional value
Top 5
33.8%
Jun 2023 → Mar 2026 · range 31.9% – 50.3%
of institutional value
Top 10
51.2%
Jun 2023 → Mar 2026 · range 51.2% – 79.1%
of institutional value
HHI
353
Jun 2023 → Mar 2026 · range 349 – 718
Broadly held
Showing 100 of 259
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1819790 CUSIP 87650L103 13F (30d) 32 filings 32 filers Visit website Investor relations